Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

'Prevention of Tumour Cell Entrapment in Local-Regional Control of Gynecologic Cancer'

Biographies

Paul Sugarbaker

Dr Paul Hendrick Sugarbaker has been at the Washington Cancer Institute since 1989 as Director for the Program in Peritoneal Surface Malignancy. His interests are in gastrointestinal cancer, gynecologic malignancy and mesothelioma. Dr Sugarbaker is a strong critic of surgical tradition; he believes that major changes in the technology of cancer resection are necessary. His theme, ‘It’s what the surgeon doesn’t see that kills the patient’, summarizes the concepts behind many of his publications in the peer-reviewed medical literature. In the opinion of Dr Sugarbaker, perioperative intravenous and intraperitoneal chemotherapy are an essential planned part of many cancer interventions.

 

Mr Hooman Soleymani majdMr Hooman Soleymani Majd started his Obstetrics and Gynaecology career in London, before moving to Oxford where he completed his structured postgraduate training programme. During the course of training he obtained his Member of the Royal College of Obstetricians and Gynaecologists (MRCOG), which culminated in a Certificate of Completion of Training (CCT) in Obstetrics and Gynaecology. Mr. Soleymani Majd completed a further three years of Sub-Specialty Training in Gynaecological Oncology at the Churchill Cancer Centre in Oxford and is also a BSCCP accredited Colposcopist, as well as a member of the British Gynaecological Cancer Society (BGCS).

He is an accomplished and experienced advanced laparoscopic surgeon, performing complex radical laparoscopic surgeries for uterine and cervical cancer. He has a special interest in performing ultra-radical surgery for ovarian cancer; his skill set includes upper abdominal surgery, liver mobilisation and diaphragmatic reconstruction. Mr Soleymani Majd also has a particular surgical interest in treating patients with Abnormally Invasive Placentas (AIP).

Mr Soleymani Majd has active involvement in teaching registrars/fellows and medical students from Oxford University. He is part of an Oxford research group that has a special interest in new developments in surgical techniques in ultra-radical surgery for advanced ovarian cancer, he has published many papers and been invited to speak at a number of international congresses.

Mr Soleymani Majd currently works as a Consultant in Gynaecological Oncology at the Churchill Hospital, Oxford.

 

The Chief Medical Officer has confirmed that attendance at the Surgical Grand Rounds can count toward internal CPD, with 1 point awarded per hour. Please note that in-person attendance is required, and you will need to sign the attendance register.

All members of the University and NHS clinical staff are welcome.

Please email Louise King if you would like to attend online.